Is BRETIGEA safe to use?

BRETIGEA has no known vulnerabilities on the latest version (1.0.3). DepScope rates its health at 36/100 (critical risk).

What is the latest version of BRETIGEA?

The latest version of BRETIGEA is 1.0.3, released 2021-05-05.

Does BRETIGEA have known vulnerabilities?

No known vulnerabilities on the latest version of BRETIGEA.

Is BRETIGEA deprecated?

No, BRETIGEA is actively maintained. Latest release: 1.0.3 (2021-05-05).

What are alternatives to BRETIGEA?

DepScope has no curated alternatives for BRETIGEA at this time.

What license does BRETIGEA use?

BRETIGEA is licensed under MIT + file LICENSE.

BRETIGEA

cranv1.0.3

Brain Cell Type Specific Gene Expression Analysis. Analysis of relative cell type proportions in bulk gene expression data. Provides a well-validated set of brain cell type-specific marker genes derived from multiple types of experiments, as described in McKenzie (2018) <doi:10.1038/s41598-018-27293-5>. For brain tissue data sets, there are marker g

License MIT + file LICENSE0 versions1 maintainers0 deps74 weekly dl

https://CRAN.R-project.org/package=BRETIGEA

/ 100

Health

use with caution

[email protected] low health (36/100) — consider alternatives

Low health score (36/100)

Health breakdown0 – 100

0/25

maintenance

0/20

popularity

25/25

security

9/15

maturity

2/15

community

Vulnerabilities

none known

Health History

Dependency Tree

License Audit

API access

Get this data programmatically — free, no authentication.

curl https://depscope.dev/api/check/cran/BRETIGEA

First published · 2021-05-05 05:56:36

Last updated · 2021-05-05T03:40:02+00:00